[1] Sarah A Hughes, Heiner Wedemeyer, Phillip M Harrison. Hepatitis delta virus. Lancet. 2011; 378(9785):73-85.
[2] EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B Virus Infection. J Hepatol. 2012; 57(1):167-185.
[3] Alvarado-Mora MV, Locarnini S, Rizzetto M, Pinho JR. An update on HDV: virology, pathogenesis and treatment. Antivir Ther. 2013; 18(3 Pt B):541-548.
[4] Botelho-Souza LF, Souza Vieira D, de Oliveira Dos Santos A, Cunha Pereira AV, Villalobos-Salcedo JM. Characterization of the Genotypic Profile of Hepatitis Delta Virus: Isolation of HDV Genotype-1 in the Western Amazon Region of Brazil. Intervirology. 2015; 58(3):166–171.
[5] Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol.2010; 7:31-40.
[6] Butt FA, Amin I, Idrees M, Iqbal M (2014) Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan. Eur J Gastroenterol Hepatol. 26(3):319–324.
[7] Bulut Y, Bahcecioglu IH, Aygun C, Oner PD, Ozercan I, Demirdag K. High genetic diversity of hepatitis delta virus in eastern Turkey. J Infect Dev Ctries. 2014; 8(1):74–78.
[8] Zaigham Abbas, Wasim Jafri, Sajjad Raza. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol. World J Gastroenterol. 2010; 16(5):554-562.
[9] Imazeki F, Omata M, Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol. 1990; 64(11): 5594–5599.
[10] Hsi-Hsun Lin, Susan Shin-Jung Lee, Ming-Lung Yu, Ting-Tsung Chang, Chien-Wei Su, Bor-Shen Hu, Yaw-Sen Chen, Chun-Kai Huang, Chung-Hsu Lai, Jiun-Nong Lin, et al. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program. Hepatology. 2015; 61(6): 1870–1879.
[11] Y Arakawa, M Moriyama, M Taira, N Hayashi, N Tanaka, H Okubo, M Sugitani. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat. 2000; 7(5):375–381.
[12] Valeria Ivaniushina, Nadjia Radjef, Marfa Alexeeva, Elyanne Gault, Sergei Semenov, Mohammed Salhi, Oleg Kiselev, Paul Dény. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol. 2001; 82(Pt 11):2709–2718.
[13] Diana di Filippo Villa, Fabian Cortes-Mancera, Edra Payares, Neyla Montes, Fernando de la Hoz, Maria Patricia Arbelaez, Gonzalo Correa, Maria-Cristina Navas. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia. Virol J. 2015; 12:172.
[14] Alvarado-Mora MV, Romano CM, Gomes-Gouvea MS, Gutierrez MF, Carrilho FJ, Pinho JR. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America. Infect Genet Evol. 2011; 11(6):1462–1468.
[15] Frédéric Le Gal, Elyanne Gault, Marie-Pierre Ripault, Jeanne Serpaggi, Jean-Claude Trinchet, Emmanuel Gordien, Paul Dény. Eighth major clade for hepatitis delta virus. Emerg Infect Dis. 2006; 12(9):1447–1450.
[16] Iris E Andernach, Lukas V Leiss, Zekiba S Tarnagda, Marc C Tahita, Jesse A Otegbayo, Joseph C Forbi, Sunday Omilabu, Ionela Gouandjika-Vasilache, Narcisse P Komas, Okwen P Mbah, et al. Characterization of hepatitis delta virus in sub-Saharan Africa. J Clin Microbiol. 2014; 52(5):1629–1636.
[17] Baolin Liao, Fuchun Zhang, Siwei Lin, Haolan He, Yu Liu, Jiansheng Zhang, Ying Xu, Junqing Yi, Yunqing Chen, Huiyuan Liu, et al. Epidemiological, Clinical and Histological Characteristics of HBV/HDV Co-Infection: A Retrospective Cross-Sectional Study in Guangdong, China. PLoS One. 2014; 9: e115888.
[18] Antonella Olivero, Antonina Smedile. Hepatitis delta virus diagnosis. Semin Liver Dis. 2012; 32(3):220-227.
[19] Chen X, Oidovsambuu O, Liu P, Grosely R, Elazar M, Winn VD, Fram B, Boa Z, Dai H, Dashtseren B, et al. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians. Hepatology 2017; 66(6): 1739-1749.
[20] Le Gal F, Brichler S, Sahli R, Chevret S, Gordien E. First international external quality assessment for hepatitis delta virus RNA quantification in plasma. Hepatology.2016; 64(5):
1483-1494.
[21] Andernach IE, Leiss LV, Tarnagda ZS, Tahita MC, Otegbayo JA, Forbi JC, Omilabu S, Gouandjika-Vasilache I, Komas NP, Mbah OP, et al. Characterization of hepatitis delta virus in sub-Saharan Africa. Journal of clinical microbiology. 2014; 52(5):1629-1636.
[22] Ling Gong, Yue Han, Li Chen, Feng Liu, Pei Hao, Jia Sheng, Xin-Hua Li, De-Min Yu, Qi-Ming Gong, Fei Tian, et al. Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity. J Clin Microbiol. 2013; 51(12):4087-4094.
[23] Jay Shendure, Gregory J Porreca, Nikos B Reppas, Xiaoxia Lin, John P McCutcheon, Abraham M Rosenbaum, Michael D Wang, Kun Zhang, Robi D Mitra, George M Church. Accurate multiplex polony sequencing of an evolved bacterial genome. Science. 2005; 309(5741):1728-1732.
[24] Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008; 26(10):1135-45.
[25] Hsuan Hui Shih, King-Song Jeng, Wan-Jr Syu, Yi-Hsiang Huang, Chien-Wei Su, Wei-Li Peng, I-Jane Sheen, Jaw-Ching Wu. Hepatitis B Surface Antigen Levels and Sequences of Natural Hepatitis B Virus Variants Influence the Assembly and Secretion of Hepatitis D Virus. J Virol. 2008; 82(5): 2250-2264.
[26] M Rizzetto, M G Canese, S Aricò, O Crivelli, C Trepo, F Bonino, G Verme. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977; 18(12): 997-1003.
[27] Heiner Wedemeyer, Michael P Manns. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7(1):31-40.
[28] Khalid Mumtaz, Saeed S Hamid, Salman Adil, Asim Afaq, M Islam, Shahab Abid, Hasnain A Shah, Wasim Jafri. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. J Gastroenterol Hepatol. 2005; 20(10):1503-1507.
[29] Rizzetto M, Ponzetto A, Forzani. Hepatitis delta virus as a global health problem. Vaccine. Vaccine. 1990; 8 Suppl:S10-4.
[30] Bui Tien Sy, Boris A Ratsch, Nguyen Linh Toan, Le Huu Song, Christian Wollboldt, Agnes Bryniok, Hung Minh Nguyen, Hoang Van Luong, Thirumalaisamy P Velavan, Heiner Wedemeyer, et al. High prevalence and significance of hepatitis D virus infection among treatment-naive HBsAg-positive patients in Northern Vietnam. PLoS One. 2013; 8(10):e78094.
[31] Benjamin Heidrich, Beatriz C Serrano, Ramazan Idilman, Gökhan Kabaçam, Birgit Bremer, Regina Raupach, Fatih O Önder, Katja Deterding, Behrend J Zacher, Andrzej Taranta, et al. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome. Liver Int. 2012; 32(9):1415–1425.